Hehe Cui

517 total citations
20 papers, 372 citations indexed

About

Hehe Cui is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Epidemiology. According to data from OpenAlex, Hehe Cui has authored 20 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 9 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Hehe Cui's work include Lipid metabolism and disorders (9 papers), Cancer-related molecular mechanisms research (8 papers) and Acute Myocardial Infarction Research (6 papers). Hehe Cui is often cited by papers focused on Lipid metabolism and disorders (9 papers), Cancer-related molecular mechanisms research (8 papers) and Acute Myocardial Infarction Research (6 papers). Hehe Cui collaborates with scholars based in China and United States. Hehe Cui's co-authors include Hongwei Li, Hui Chen, Yuejin Yang, Weiping Li, Jin Chen, Xiaosong Ding, Chen Jin, Xiaqiu Tian, Na Li and Xiangdong Li and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Journal of Ethnopharmacology.

In The Last Decade

Hehe Cui

18 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hehe Cui China 12 195 133 93 70 59 20 372
Jingmin Zhou China 14 207 1.1× 240 1.8× 126 1.4× 57 0.8× 53 0.9× 34 498
Xiaosheng Hu China 12 136 0.7× 220 1.7× 73 0.8× 70 1.0× 29 0.5× 29 470
Joke Breyne Belgium 10 164 0.8× 97 0.7× 79 0.8× 46 0.7× 24 0.4× 18 444
Na Zhou China 13 124 0.6× 277 2.1× 104 1.1× 87 1.2× 18 0.3× 35 537
Dina Xie United States 11 133 0.7× 203 1.5× 76 0.8× 59 0.8× 24 0.4× 16 379
Ruizhen Chen China 9 260 1.3× 317 2.4× 181 1.9× 44 0.6× 36 0.6× 24 584
Americo Simonini United States 6 227 1.2× 146 1.1× 43 0.5× 49 0.7× 152 2.6× 6 472
Jiachen Luo China 12 196 1.0× 106 0.8× 30 0.3× 46 0.7× 13 0.2× 33 361
Hexiang Cheng China 7 117 0.6× 269 2.0× 41 0.4× 69 1.0× 18 0.3× 15 480

Countries citing papers authored by Hehe Cui

Since Specialization
Citations

This map shows the geographic impact of Hehe Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hehe Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hehe Cui more than expected).

Fields of papers citing papers by Hehe Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hehe Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hehe Cui. The network helps show where Hehe Cui may publish in the future.

Co-authorship network of co-authors of Hehe Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Hehe Cui. A scholar is included among the top collaborators of Hehe Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hehe Cui. Hehe Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Li, et al.. (2023). Characteristics of Wellens’ Syndrome in the Current PCI Era: A Single-Center Retrospective Study. Emergency Medicine International. 2023. 1–8. 4 indexed citations
2.
Jiang, Xuejiao, Chongyang Ma, Yanbin Gao, et al.. (2022). Tongxinluo attenuates atherosclerosis by inhibiting ROS/NLRP3/caspase-1-mediated endothelial cell pyroptosis. Journal of Ethnopharmacology. 304. 116011–116011. 32 indexed citations
3.
Zhou, Li, et al.. (2022). Wellens’ syndrome: incidence, characteristics, and long-term clinical outcomes. BMC Cardiovascular Disorders. 22(1). 176–176. 12 indexed citations
4.
6.
Chen, Hui, et al.. (2022). The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention. Scandinavian Journal of Clinical and Laboratory Investigation. 82(4). 304–310. 13 indexed citations
7.
Cui, Hehe, Xiao Zhang, Xiaosong Ding, et al.. (2021). Urinary Alpha1-Microglobulin: A New Predictor for In-Hospital Mortality in Patients with ST-Segment Elevation Myocardial Infarction. Medical Science Monitor. 27. e927958–e927958. 3 indexed citations
10.
Cui, Hehe, Xiaosong Ding, Weiping Li, Hui Chen, & Hongwei Li. (2019). The Neutrophil Percentage to Albumin Ratio as a New Predictor of In-Hospital Mortality in Patients with ST-Segment Elevation Myocardial Infarction. Medical Science Monitor. 25. 7845–7852. 64 indexed citations
11.
Kang, Qi, Xiangdong Li, Yong‐Jian Geng, et al.. (2018). Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway. PLoS ONE. 13(6). e0198403–e0198403. 18 indexed citations
12.
Hua, Bing, Qingbo Liu, Hehe Cui, Hui Chen, & Hongwei Li. (2017). TCTAP A-051 Nicorandil Protects Cardiac Microvascular Endothelial Cells from Advanced Glycation End Products Induced Cytotoxicity by Promoting Autophagy. Journal of the American College of Cardiology. 69(16). S27–S27.
13.
Li, Qing, Hehe Cui, Xiaqiu Tian, et al.. (2017). Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo. Cellular Physiology and Biochemistry. 41(4). 1503–1518. 21 indexed citations
14.
Xu, Chuansheng, Jie Zhang, Qing Li, et al.. (2017). Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1. Frontiers in Pharmacology. 8. 775–775. 35 indexed citations
15.
16.
Cui, Hehe, Na Li, Xiangdong Li, et al.. (2016). Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury.. PubMed. 8(10). 4370–4381. 16 indexed citations
17.
Kang, Qi, Lujin Li, Xiangdong Li, et al.. (2015). Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury. PLoS ONE. 10(3). e0119846–e0119846. 22 indexed citations
18.
Cui, Hehe, Na Li, Qing Li, et al.. (2014). Induction of Autophagy by Tongxinluo Through the MEK/ERK Pathway Protects Human Cardiac Microvascular Endothelial Cells From Hypoxia/Reoxygenation Injury. Journal of Cardiovascular Pharmacology. 64(2). 180–190. 56 indexed citations
19.
Li, Na, Yuejin Yang, Hehe Cui, et al.. (2013). Tongxinluo Decreases Apoptosis of Mesenchymal Stem Cells Concentration-dependently Under Hypoxia and Serum Deprivation Conditions Through the AMPK/eNOS Pathway. Journal of Cardiovascular Pharmacology. 63(3). 265–273. 14 indexed citations
20.
Li, Xiangdong, et al.. (2012). [Ischemic preconditioning attenuates myocardial no-reflow and reperfusion injury after revascularization of acute myocardial infarction by reducing myocardial edema via the protein kinase A pathway].. PubMed. 40(11). 945–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026